Quantum Genesis AI Corp. (QGAI)

Market Cap	5.51M -22.4%
Revenue (ttm)	n/a
Net Income	-4.44M
EPS	-0.12
Shares Out	40.97M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	625
Open	0.1599
Previous Close	0.0700
Day's Range	0.1344 - 0.1599
52-Week Range	0.0011 - 5.0400
Beta	9.09
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 17, 2026

About Quantum Genesis AI

Quantum Genesis AI Corp., a biotransformation company, focuses on advancing enzyme-based solutions for pharmaceutical manufacturing. It utilizes customer centric research to enhance enzyme activity, by applying quantum mechanics, molecular modelling, AI-driven simulations, and computational enzyme engineering to develop biocatalysts designed to enhance efficiency, reduce waste, and support production. The company was formerly known as Quantumzyme Corp. and changed its name to Quantum Genesis AI Corp. in February 2026. Quantum Genesis AI Corp. w...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2015
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: QGAI

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 20, 2026

Data Sources Report a data error